LNSR Q4 2020 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M-2.1% YoY

Gross Profit

$5M56.3% margin

Operating Income

-$7M-82.7% margin

Net Income

-$7M-82.4% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+15.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$79M

Total Liabilities

$12M

Stockholders' Equity

$67M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-2.1%
Gross Profit	$5M	$5M	+0.0%
Operating Income	-$7M	-$2M	-254.6%
Net Income	-$7M	-$2M	-176.7%

Revenue Segments

Product

$6M90%

Service

$731,00010%

Geographic Segments

UNITED STATES

$4M56%

Europe

$1M18%

KOREA, REPUBLIC OF

$1M14%

Asia Excluding South Korea

$746,00010%

Other Geographical Region

$95,0001%